DISCOVERY, DEVELOPMENT, DEPLOYMENTFOR GLOBAL HEALTH, with SCIENCE & BUSINESS ACUMEN
MISSION
We are a professional firm that can DISCOVER technological seeds and ideas, DEVELOP them into viable products and services, and DEPLOY to the society to improve global health partnering with established corporations who share our passion
BUSINESS
INVESTMENTS
■ D3 Bio Healthcare Fund
− Venture Capital (LPS in Japan)
− FOCUS: Early Stage biotech and digital healthcare start-ups
with tech and idea potentially contribute to global
health issues
CONSULTING
■ Management advisory
■ Investment advisory
− Growth Strategy (Corporate, Business)
− New Business Development
− Innovation
− Private Equity (buyout)
− Growth Capital
TEAM
#PARTNERS
TOMOYA NAGATA, M.S. R.Ph.
Managing Partner, CEO
FIL Capital Management (HK) Ltd. | McKinsey (Strategy & Innovation) | M.S. and B.S. in Pharma. Sci., Univ. of Tokyo | UC Berkley HaaS VCEP | Registered Pharmacist
KENJI WATATANI, Ph.D.Partner, COO
McKinsey (Pharmaceuticals & Medical Products) | PD in Kyoto Univ. (iCeMS)| Ph.D. in Mol. Biol., Univ. of Tokyo
#VENTURE PARTNERS
YUJI SUZUKI, M. Phil.Venture Partner (China)
Human Metabolome Technologies (Exec. Officer) | Macromill (Global Strategy) | McKinsey (Greater China, Japan) | Financial Services Agency | Ministry of Foreign Affairs | M.Phil., Univ. of Cambridge | B.A., Univ. of Tokyo
YASUAKI HASEBE, M.D.
Venture Partner
Activaid (Founder CEO) | Novartis (Basel, Tokyo) | McKinsey | M.D., Nagoya Univ.